95 related articles for article (PubMed ID: 28966067)
21. Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
Huang BS; Chen WY; Hsieh CE; Lin CY; Lee LY; Fang KH; Tsang NM; Kang CJ; Wang HM; Chang JT
Jpn J Clin Oncol; 2016 Sep; 46(9):832-8. PubMed ID: 27317738
[TBL] [Abstract][Full Text] [Related]
22. Mandibular growth in survivors of pediatric parotid gland carcinoma treated with interstitial brachytherapy.
Wu WJ; Huang MW; Zhang GH; Zhao D; Zheng L; Yu GY; Zhang JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27223. PubMed ID: 29797637
[TBL] [Abstract][Full Text] [Related]
23. [125I seed implant brachytherapy of recurrent parotid gland malignant tumor].
Zhang J; Zhang JG; Cai ZG; Zhang Y; Huang MX; Yu GY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jan; 44(1):2-4. PubMed ID: 19489249
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary study of treating parotid gland malignant tumor with saving facial nerve (surgery associated with 125I seed implant brachytherapy)].
Zhanf JG; Zhang J; Song TL; Zheng L; Cai ZG; Yu GY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):132-5. PubMed ID: 18788543
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
27. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
Tullio A; Marchetti C; Sesenna E; Brusati R; Cocchi R; Eusebi V
J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
[TBL] [Abstract][Full Text] [Related]
28. Definitive
Xu N; Zheng L; Wu WJ; Huang MW; Zhang J; Zhang JG
J Oral Maxillofac Surg; 2019 Oct; 77(10):2143-2153. PubMed ID: 31028735
[TBL] [Abstract][Full Text] [Related]
29. Radioactive seed migration following parotid gland interstitial brachytherapy.
Fan Y; Huang MW; Zhao YJ; Gao H; Zhang JG
Brachytherapy; 2017; 16(6):1219-1224. PubMed ID: 28927732
[TBL] [Abstract][Full Text] [Related]
30. Survival in patients with parotid gland carcinoma - Results of a multi-center study.
Honda K; Tanaka S; Shinohara S; Asato R; Tamaki H; Maetani T; Tateya I; Kitamura M; Takebayashi S; Ichimaru K; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Mizuta M; Yamada K; Omori K
Am J Otolaryngol; 2018; 39(1):65-70. PubMed ID: 29089142
[TBL] [Abstract][Full Text] [Related]
31. Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome.
Chen AM; Lau VH; Farwell DG; Luu Q; Donald PJ
Laryngoscope; 2013 Dec; 123(12):3049-55. PubMed ID: 23754320
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Parotid Malignancies—10 Years of Experience.
Kopeć T; Mikaszewski B; Jackowska J; Waśniewska-Okupniak E; Szyfter W; Wierzbicka M
J Oral Maxillofac Surg; 2015 Jul; 73(7):1397-402. PubMed ID: 25850920
[TBL] [Abstract][Full Text] [Related]
33. A case-cohort study of recurrent salivary adenoid cystic carcinoma after iodine 125 brachytherapy and resection treatment.
Li BB; Xie XY; Jia SN
Ann Diagn Pathol; 2015 Feb; 19(1):1-5. PubMed ID: 25496646
[TBL] [Abstract][Full Text] [Related]
34. Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins.
Wu WJ; Shao X; Huang MW; Lv XM; Zhang XN; Zhang JG
Head Neck; 2017 Mar; 39(3):572-577. PubMed ID: 28075511
[TBL] [Abstract][Full Text] [Related]
35. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.
Cederblad L; Johansson S; Enblad G; Engström M; Blomquist E
Acta Oncol; 2009; 48(4):549-55. PubMed ID: 19140053
[TBL] [Abstract][Full Text] [Related]
36. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
Tan LT; Jones B; Gee A; Kingston RE
Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
[TBL] [Abstract][Full Text] [Related]
37. Analysis of acinic cell carcinoma of the parotid gland - 15 years experience.
Lin WN; Huang HC; Wu CC; Liao CT; Chen IH; Kan CJ; Huang SF
Acta Otolaryngol; 2010 Dec; 130(12):1406-10. PubMed ID: 20809887
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological factors are predictors of distant metastasis from major salivary gland carcinomas.
Mariano FV; da Silva SD; Chulan TC; de Almeida OP; Kowalski LP
Int J Oral Maxillofac Surg; 2011 May; 40(5):504-9. PubMed ID: 21251798
[TBL] [Abstract][Full Text] [Related]
39. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
40. Postoperative 125I brachytherapy delivered by digital model obturators for recurrent or locally advanced maxillary cancers.
Huang MW; Zhang JG; Tong D; Zhang J; Zheng L; Zhang Y; Yu GY
Laryngoscope; 2012 Nov; 122(11):2461-7. PubMed ID: 22965822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
